XML 39 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (USD $)
Total
Common Stock
Preferred Stock B
Preferred Stock B
Preferred Stock A
Preferred Stock A
Additional Paid-In Capital
Additional Paid-In Capital
Preferred Stock A
Additional Paid-In Capital
Preferred Stock B
Deficit Accumulated During the Development Stage
Deficit Accumulated During the Development Stage
Preferred Stock A
Deficit Accumulated During the Development Stage
Preferred Stock B
Beginning Balance at Dec. 31, 2011 $ 318,343.00 $ 177,626.00 $ 65.00   $ 1,447.00   $ 92,696,747.00     $ (92,557,542.00)    
Beginning Balance (in shares) at Dec. 31, 2011   177,626,058.00 65,433.34   1,447,159.00              
Stock based compensation - employees, consultants and directors 4,532           4,532          
Issuance of Preferred Stock as dividends (in shares)       3,307.91   73,190            
Issuance of Preferred Stock as dividends (1,241,121)     4.00   73   8,616 1,232,428.00   (8,689) (1,232,432.00)
Conversion of Series A and Series B into Common (in shares)   418,633.00 (140.87)   (3,003.00)              
Conversion of Series A and Series B into Common   419.00     (3.00)   (416.00)          
Issuance of common stock for cash, net of cost of raising capital (in shares)   17,056,867                    
Issuance of common stock for cash, net of cost of raising capital 2,260,153 17,057         2,243,096          
Conversion of convertible notes to common (in shares) 3,951,540 3,951,540                    
Conversion of convertible notes to common 395,153 3,951         391,202          
Relative fair value of warrants and beneficial conversion feature in connection with issuance of convertible note 87,700           87,700          
Net loss (2,473,906)                 (2,473,906)    
Ending Balance at Jun. 30, 2012 $ 591,975.00 $ 199,053.00 $ 69.00   $ 1,517.00   $ 96,663,905.00     $ (96,272,569.00)    
Ending Balance (in shares) at Jun. 30, 2012   199,053,098.00 68,600.38   1,517,346.00